ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

DCT Adopts New Unsolicited Contract Review Procedures

May 21, 1976

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002